Back to Noidecs or All Flower/Bud

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This product was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Terpene Profile (Strain Estimate)

Alpha-PineneMajorPine/Sharp156℃
Beta-PineneMajorPine/Herbal165℃
CareneMajorEarthy/Sweet168℃

MedBud currently tracks 16 common terpenes, more will be added.

Medication Details

Brand
United Kingdom Noidecs
Designation
T20
Cultivar/Strain
Murray Sherbet
Classification
Indica
Chemotype
Type I: High THC
THC Potential Range (±10%)
20%
CBD Potential Range (±10%)
<1%
Cultivated/Produced by
Australia ECS Botanics
Cultivated or Packaged in
Flag of Australia Australia
Imported by
United Kingdom Eaststone
Irradiation
Gamma-Irradiated
Flower Provided
Whole Bud

Stock Availability

We provide stock and pharmacy information for medical cannabis patients only. Cannabis is a controlled substance in the UK and can only be dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed here.

Best Known Status: Available

Dispensing Pharmacies

Project Twenty21

Available on T21, a research project offering participating patients several discounted medications:

Participating Pharmacies:
Product DescriptionPatient Reviews

About Murray Sherbet

MurIndica

A proprietary strain from Lyphe by a currently unknown cultivator.

Proprietary Strain

Little is known about this strain other than it being bred in-house by the cultivator. We cannot currently confirm the origins of this strain, including its genetic lineage.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

United Kingdom About Lyphe Group Ltd

Noidecs Logo

From Lyphe Group, a range of medical flowers and oils focused on giving doctors reassurance in the efficiency and consistency of our supply chain, while providing quality pharmaceutical-grade medication.

At Lyphe our vertical operations span product manufacturing, clinical care, pharmacy dispensing and doctor education. Our direct-to-patient and technology-led approach has quickly established us as the market’s largest player, with a 30% share of all patients. We have also recently entered the Australian market, where we intend to replicate our model of success.

lyphegroup.com

  New government petition approved: Introduce 'Grow Your Own' Laws for Legal Medical Cannabis Patients (CBPM) — please sign and share. 6 months to achieve 10,000 signatures.

  Information provided is partially community-sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)